Joseph M. Limber - 15 May 2024 Form 4 Insider Report for XOMA Corp (XOMA)

Role: Director
Signature: /s/ Thomas Burns, Attorney-in-Fact for Joseph M Limber
Issuer symbol: XOMA
Transactions as of: 15 May 2024
Net transactions value: $0
Form type: 4
Filing time: 17 May 2024, 16:30:40 UTC
Previous filing: 19 May 2023
Next filing: 07 Apr 2025
SEC: View on sec.gov

Quoteable Key Fact

"Joseph M. Limber filed Form 4 for XOMA Corp (XOMA) on 17 May 2024."

Quick Takeaways

This page summarizes Joseph M. Limber's Form 4 filing for XOMA Corp (XOMA).
1 reported transaction and 1 derivative row are listed below.
Filing timestamp: 17 May 2024, 16:30.

What Changed

Previous filing in this sequence was filed on 19 May 2023.
Current net transaction value: $0.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XOMA	Non-Qualified Share Option (right to buy)	Award	$0	+9,763		$0.000000	9,763	15 May 2024	Common Shares	9,763	$24.71	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option shall vest and become exercisable in equal monthly installments over the 12-month period following the date of grant (May 15, 2024), provided that the final installment will occur on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the reporting person's continued service to the Company through each vesting date.

Content

The shares subject to this option shall vest and become exercisable in equal monthly installments over the 12-month period following the date of grant (May 15, 2024), provided that the final installment will occur on the earlier of (i) the date of the next annual meeting of the Company's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the reporting person's continued service to the Company through each vesting date.